Contraception

IND Filed for Seasonale Oral Contraceptive

Published in Women's Health Weekly, June 8th, 2000

Barr Laboratories, Inc. (BRL), Pomona, New York, announced that it has filed an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for its Seasonale proprietary oral contraceptive product.

Speaking at the UBS Warburg Dillon Read Global Specialty Pharmaceuticals Conference in New York City, Bruce L. Downey, Barr said that patient recruitment for the Phase III clinical studies could begin as early as Summer 2000.

Seasonale is an innovative patent-protected oral contraceptive product being developed through an agreement with the Medical College of Hampton Roads, Eastern Virginia Medical School (EVMS).

...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Source: Women's Health Weekly (2000-06-08)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry